AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
EVALUATION OF ENALAPRIL COMBINED WITH DILTIAZEM ER IN PATIENTS WITH STAGE-3-4 ESSENTIAL-HYPERTENSION
Authors: GAVRAS H CHRYSANT SG NIEDERMAN AL MARBURY TC GOLDSTEIN R CONRADI E
Citation: H. Gavras et al., EVALUATION OF ENALAPRIL COMBINED WITH DILTIAZEM ER IN PATIENTS WITH STAGE-3-4 ESSENTIAL-HYPERTENSION, Clinical and experimental hypertension, 20(1), 1998, pp. 41-52
FIXED LOW-DOSE DRUG-COMBINATION FOR THE TREATMENT OF HYPERTENSION
Authors: CHRYSANT SG
Citation: Sg. Chrysant, FIXED LOW-DOSE DRUG-COMBINATION FOR THE TREATMENT OF HYPERTENSION, Archives of family medicine, 7(4), 1998, pp. 370-376
PHASE-III MULTICENTER TRIAL COMPARING THE EFFICACY OF 2-PERCENT DODECAFLUOROPENTANE EMULSION (ECHOGEN) AND SONICATED 5-PERCENT HUMAN ALBUMIN (ALBUNEX) AS ULTRASOUND CONTRAST AGENTS IN PATIENTS WITH SUBOPTIMAL ECHOCARDIOGRAMS
Authors: GRAYBURN PA WEISS JL HACK TC KLODAS E RAICHLEN JS VANNAN MA KLEIN AL KITZMAN DW CHRYSANT SG COHEN JL ABRAHAMSON D FOSTER E PEREZ JE AURIGEMMA GP PANZA JA PICARD MH BYRD BF SEGAR DS JACOBSON SA SAHN DJ DEMARIA AN
Citation: Pa. Grayburn et al., PHASE-III MULTICENTER TRIAL COMPARING THE EFFICACY OF 2-PERCENT DODECAFLUOROPENTANE EMULSION (ECHOGEN) AND SONICATED 5-PERCENT HUMAN ALBUMIN (ALBUNEX) AS ULTRASOUND CONTRAST AGENTS IN PATIENTS WITH SUBOPTIMAL ECHOCARDIOGRAMS, Journal of the American College of Cardiology, 32(1), 1998, pp. 230-236
INFLUENCE OF RACE AND DIETARY SALT ON THE ANTIHYPERTENSIVE EFFICACY OF AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR A CALCIUM-CHANNEL ANTAGONIST IN SALT-SENSITIVE HYPERTENSIVES
Authors: WEIR MR CHRYSANT SG MCCARRON DA CANOSSATERRIS M COHEN JD GUNTER PA LEWIN AJ MENNELLA RF KIRKEGAARD LW HAMILTON JH WEINBERGER MH WEDER AB
Citation: Mr. Weir et al., INFLUENCE OF RACE AND DIETARY SALT ON THE ANTIHYPERTENSIVE EFFICACY OF AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR A CALCIUM-CHANNEL ANTAGONIST IN SALT-SENSITIVE HYPERTENSIVES, Hypertension, 31(5), 1998, pp. 1088-1096
ANTIHYPERTENSIVE EFFECTIVENESS OF A VERY-LOW FIXED-DOSE COMBINATION OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE
Authors: CHRYSANT SG STIMPEL M
Citation: Sg. Chrysant et M. Stimpel, ANTIHYPERTENSIVE EFFECTIVENESS OF A VERY-LOW FIXED-DOSE COMBINATION OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE, Journal of cardiovascular pharmacology, 31(3), 1998, pp. 384-390
LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
Authors: CHRYSANT SG WOMBOLT DG FELICIANO N ZHENG HJ
Citation: Sg. Chrysant et al., LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Current therapeutic research, 59(11), 1998, pp. 762-772
THE ROLE OF VASCULAR HEALTH IN HYPERTENSION MANAGEMENT - INTRODUCTION
Authors: CHRYSANT SG
Citation: Sg. Chrysant, THE ROLE OF VASCULAR HEALTH IN HYPERTENSION MANAGEMENT - INTRODUCTION, The American heart journal, 135(2), 1998, pp. 1-1
VASCULAR REMODELING - THE ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
Authors: CHRYSANT SG
Citation: Sg. Chrysant, VASCULAR REMODELING - THE ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, The American heart journal, 135(2), 1998, pp. 21-30
ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL - A DOUBLE-BLIND COMPARISON WITH DILTIAZEM-CD
Authors: MASSIE BM CHRYSANT SG JAIN A WEIR M WEISS R KOBRIN I
Citation: Bm. Massie et al., ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL - A DOUBLE-BLIND COMPARISON WITH DILTIAZEM-CD, Clinical cardiology, 20(6), 1997, pp. 562-568
CLINICAL UTILITY OF LONG-TERM ENALAPRIL DILTIAZEM ER IN STAGE-3-4 ESSENTIAL-HYPERTENSION
Authors: CHRYSANT SG GAVRAS H NIEDERMAN AL MARBURY TC GOLDSTEIN R
Citation: Sg. Chrysant et al., CLINICAL UTILITY OF LONG-TERM ENALAPRIL DILTIAZEM ER IN STAGE-3-4 ESSENTIAL-HYPERTENSION, Journal of clinical pharmacology, 37(9), 1997, pp. 810-815
PERINDOPRIL HYDROCHLOROTHIAZIDE DOSE COMBINATIONS FOR THE TREATMENT OF HYPERTENSION - A MULTICENTER STUDY/
Authors: CHRYSANT SG
Citation: Sg. Chrysant, PERINDOPRIL HYDROCHLOROTHIAZIDE DOSE COMBINATIONS FOR THE TREATMENT OF HYPERTENSION - A MULTICENTER STUDY/, Journal of clinical pharmacology, 37(1), 1997, pp. 47-52
LONG-TERM ANTIHYPERTENSIVE EFFECTS WITH CHRONIC ADMINISTRATION OF ISRADIPINE CONTROLLED-RELEASE
Authors: CHRYSANT SG COHEN M
Citation: Sg. Chrysant et M. Cohen, LONG-TERM ANTIHYPERTENSIVE EFFECTS WITH CHRONIC ADMINISTRATION OF ISRADIPINE CONTROLLED-RELEASE, Current therapeutic research, 58(1), 1997, pp. 1-9
THERE ARE NO RACIAL, AGE, SEX, OR WEIGHT DIFFERENCES IN THE EFFECT OFSALT ON BLOOD-PRESSURE IN SALT-SENSITIVE HYPERTENSIVE PATIENTS
Authors: CHRYSANT SG WEIR MR WEDER AB MCCARRON DA CANOSSATERRIS M COHEN JD MENNELLA RF KIRKEGAARD LW LEWIN AJ WEINBERGER MH
Citation: Sg. Chrysant et al., THERE ARE NO RACIAL, AGE, SEX, OR WEIGHT DIFFERENCES IN THE EFFECT OFSALT ON BLOOD-PRESSURE IN SALT-SENSITIVE HYPERTENSIVE PATIENTS, Archives of internal medicine, 157(21), 1997, pp. 2489-2494
EFFECTS OF BENAZEPRIL AND HYDROCHLOROTHIAZIDE, GIVEN ALONE AND IN LOW-DOSE AND HIGH-DOSE COMBINATIONS, ON BLOOD-PRESSURE IN PATIENTS WITH HYPERTENSION
Authors: CHRYSANT SG FAGAN T GLAZER R KRIEGMAN A
Citation: Sg. Chrysant et al., EFFECTS OF BENAZEPRIL AND HYDROCHLOROTHIAZIDE, GIVEN ALONE AND IN LOW-DOSE AND HIGH-DOSE COMBINATIONS, ON BLOOD-PRESSURE IN PATIENTS WITH HYPERTENSION, Archives of family medicine, 5(1), 1996, pp. 17-24
A COMPARISON OF THE ANTIHYPERTENSIVE EFFECTIVENESS OF A COMBINATION OF MOEXIPRIL OR SUSTAINED-RELEASE VERAPAMIL WITH LOW-DOSE HYDROCHLOROTHIAZIDE
Authors: CHRYSANT SG STIMPEL M
Citation: Sg. Chrysant et M. Stimpel, A COMPARISON OF THE ANTIHYPERTENSIVE EFFECTIVENESS OF A COMBINATION OF MOEXIPRIL OR SUSTAINED-RELEASE VERAPAMIL WITH LOW-DOSE HYDROCHLOROTHIAZIDE, Journal of clinical pharmacology, 36(8), 1996, pp. 701-706
BLOOD-PRESSURE EFFECTS OF SODIUM REDUCTION COMPARED TO ISRADIPINE ANDENALAPRIL AMONG HYPERTENSIVES PRE-SELECTED FOR SODIUM SENSITIVITY
Authors: COHEN JD WEDER AB WEINBERGER MH CHRYSANT SG MCCARRON DL
Citation: Jd. Cohen et al., BLOOD-PRESSURE EFFECTS OF SODIUM REDUCTION COMPARED TO ISRADIPINE ANDENALAPRIL AMONG HYPERTENSIVES PRE-SELECTED FOR SODIUM SENSITIVITY, Circulation, 94(8), 1996, pp. 1035-1035
A PHASE-3 TRIAL COMPARING DODECAFLUOROPENTANE (ECHOGEN) AND SONICATEDALBUMIN (ALBUNEX) IN PATIENTS WITH SUBOPTIMAL ECHOES
Authors: GRAYBURN PA HACK TC WEISS JL RAICHLEN JS VANNAN MA KLEIN AL KITZMAN DW CHRYSANT SG COHEN JL ABRAHAMSON D FOSTER E PEREZ JE AURIGEMMA GP PANZA JA PICARD MH BYRD BF SEGAR DS JACOBSON SA
Citation: Pa. Grayburn et al., A PHASE-3 TRIAL COMPARING DODECAFLUOROPENTANE (ECHOGEN) AND SONICATEDALBUMIN (ALBUNEX) IN PATIENTS WITH SUBOPTIMAL ECHOES, Circulation, 94(8), 1996, pp. 3365-3365
COMPARISON OF MOEXIPRIL, A NEW ACE-INHIBITOR, TO VERAPAMIL-SR AS ADD-ON THERAPY TO LOW-DOSE HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTS
Authors: CHRYSANT SG FOX AAL STIMPEL M
Citation: Sg. Chrysant et al., COMPARISON OF MOEXIPRIL, A NEW ACE-INHIBITOR, TO VERAPAMIL-SR AS ADD-ON THERAPY TO LOW-DOSE HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTS, American journal of hypertension, 8(4), 1995, pp. 418-421
SUSTAINED BLOOD-PRESSURE CONTROL WITH CONTROLLED-RELEASE ISRADIPINE
Authors: CHRYSANT SG COHEN M
Citation: Sg. Chrysant et M. Cohen, SUSTAINED BLOOD-PRESSURE CONTROL WITH CONTROLLED-RELEASE ISRADIPINE, American journal of hypertension, 8(1), 1995, pp. 87-89
SUSTAINED BLOOD-PRESSURE CONTROL WITH CONTROLLED-RELEASE ISRADIPINE (ISRADIPINE-CR)
Authors: CHRYSANT SG COHEN M
Citation: Sg. Chrysant et M. Cohen, SUSTAINED BLOOD-PRESSURE CONTROL WITH CONTROLLED-RELEASE ISRADIPINE (ISRADIPINE-CR), Journal of clinical pharmacology, 35(3), 1995, pp. 239-243
DOSE-RANGING STUDY OF A NEW, ONCE-DAILY DILTIAZEM FORMULATION FOR PATIENTS WITH STABLE ANGINA
Authors: CUTLER NR EFF J FROMELL G BRASS EP ARCHER S CHRYSANT SG FIDDES R
Citation: Nr. Cutler et al., DOSE-RANGING STUDY OF A NEW, ONCE-DAILY DILTIAZEM FORMULATION FOR PATIENTS WITH STABLE ANGINA, Journal of clinical pharmacology, 35(2), 1995, pp. 189-195
COMPARISON OF AMLODIPINE AND BENAZEPRIL MONOTHERAPY TO AMLODIPINE PLUS BENAZEPRIL IN PATIENTS WITH SYSTEMIC HYPERTENSION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY
Authors: FRISHMAN WH RAM CVS MCMAHON FG CHRYSANT SG GRAFF A KUPIEC JW HSU H
Citation: Wh. Frishman et al., COMPARISON OF AMLODIPINE AND BENAZEPRIL MONOTHERAPY TO AMLODIPINE PLUS BENAZEPRIL IN PATIENTS WITH SYSTEMIC HYPERTENSION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY, Journal of clinical pharmacology, 35(11), 1995, pp. 1060-1066
DOXAZOSIN FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-RESPONSE MULTICENTER STUDY
Authors: GILLENWATER JY CONN RL CHRYSANT SG ROY J GAFFNEY M ICE K DIAS N
Citation: Jy. Gillenwater et al., DOXAZOSIN FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-RESPONSE MULTICENTER STUDY, The Journal of urology, 154(1), 1995, pp. 110-115
EFFECTS OF MODULATORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ON COUGH
Authors: LACOURCIERE Y BRUNNER H IRWIN R KARLBERG BE RAMSAY LE SNAVELY DB DOBBINS TW FAISON EP NELSON EB CHRYSANT SG ISRAEL R IRWIN R POOL J RYAN WM SMALLWOOD K SYNHAVSKY A WAYNE J WINER N DIENSL F WEBB D GILCHRIST N KARLBERG BE SEGURA L BRUNNER HR HERRERA J MION D MALINI PL
Citation: Y. Lacourciere et al., EFFECTS OF MODULATORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ON COUGH, Journal of hypertension, 12(12), 1994, pp. 1387-1393
EFFECTS OF ATENOLOL AND DILTIAZEM-SR ON EXERCISE AND PRESSURE LOAD INHYPERTENSIVE PATIENTS
Authors: CHRYSANT SG MILLER E BOTTI RE LEUG M MORSE I NIEDERMAN AL SANDALL P
Citation: Sg. Chrysant et al., EFFECTS OF ATENOLOL AND DILTIAZEM-SR ON EXERCISE AND PRESSURE LOAD INHYPERTENSIVE PATIENTS, Clinical cardiology, 17(12), 1994, pp. 670-674
Risultati: 1-25 | 26-30